» Articles » PMID: 20103637

PSF1, a DNA Replication Factor Expressed Widely in Stem and Progenitor Cells, Drives Tumorigenic and Metastatic Properties

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Jan 28
PMID 20103637
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

PSF1 (partner of sld five 1) is an evolutionarily conserved DNA replication factor implicated in DNA replication in lower species that is strongly expressed in a wide range of normal stem cell populations and progenitor cell populations. Because stem and progenitor cells possess high proliferative capacity, we hypothesized that PSF1 may play an important role in tumor growth. To begin to investigate PSF1 function in cancer cells, we cloned the mouse PSF1 promoter and generated lung and colon carcinoma cells that stably express a PSF1 promoter-reporter gene. Reporter expression in cells correlated with endogenous PSF1 mRNA expression. In a tumor cell xenograft model, high levels of reporter expression correlated with high proliferative activity, serial transplantation potential, and metastatic capability. Notably, cancer cells expressing reporter levels localized to perivascular regions in tumors and displayed expression signatures related to embryonic stem cells. RNAi-mediated silencing of endogenous PSF1 inhibited cancer cell growth by disrupting DNA synthesis and chromosomal segregation. These findings implicate PSF1 in tumorigenesis and offer initial evidence of its potential as a theranostic target.

Citing Articles

OTU deubiquitinase, ubiquitin aldehyde binding 2  (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression.

Zhu W, Wu C, Liu Z, Zhao S, Huang J Cell Commun Signal. 2024; 22(1):420.

PMID: 39210373 PMC: 11361113. DOI: 10.1186/s12964-024-01789-2.


Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine.

Hu D, Shen X, Gao P, Mao T, Chen Y, Li X EPMA J. 2024; 15(2):321-343.

PMID: 38841626 PMC: 11147991. DOI: 10.1007/s13167-024-00362-8.


miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication.

Fuertes T, Alvarez-Corrales E, Gomez-Escolar C, Ubieto-Capella P, Serrano-Navarro A, de Molina A Cell Death Dis. 2023; 14(10):687.

PMID: 37852959 PMC: 10585006. DOI: 10.1038/s41419-023-06178-0.


FOXP1-GINS1 axis promotes DLBCL proliferation and directs doxorubicin resistance.

Chen Z, Wang T, Li C, Zhang W, Huang W, Xue J J Cancer. 2023; 14(12):2289-2300.

PMID: 37576391 PMC: 10414051. DOI: 10.7150/jca.85906.


Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons.

Boyd R, McClymont S, Barrientos N, Hook P, Law W, Rose R BMC Genomics. 2023; 24(1):306.

PMID: 37286935 PMC: 10245633. DOI: 10.1186/s12864-023-09398-y.